IBA has four core activities: industrial solutions, radiopharmacy solutions, dosimetry and proton therapy. It develops, manufactures and supports medical devices and software solutions for cancer treatments. The company exports almost 100% of its business and is present in over 20 countries. At first, IBA exported mostly to Europe, the USA and Asia, but nowadays, the number of transactions in and to Africa and Latin America is growing.
Thomas Pevenage, Director Treasury & Financing of IBA Group, says Credendo has been a long-term partner since the creation of IBA. He highlights two Credendo solutions IBA has used for some high-profile transactions:
- the classic trade insurance policy to cover the risk of non-payment and the cancellation risk; and
- the Buyer Credit Credendo with which a company can offer an export credit to a buyer.
Nabil Jijakli, Deputy CEO of Credendo, says Credendo is proud to have been able to accompany IBA from start-up to leader in its field. Banks can be reluctant to provide loans for more risky markets. That is where Credendo can help so that a company can focus on its core business.
Discover the testimonial below: